e-learning
resources
Stockholm 2007
Monday 17.09.2007
COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can plasma arginase levels differantiate asthma and COPD?
Z. Bingol, T. Cagatay, L. Pur, B. Kiran, Z. Gulbaran, P. Cagatay, F. Erkan (Istanbul, Turkey)
Source:
Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Session:
COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Session type:
Thematic Poster Session
Number:
2226
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Bingol, T. Cagatay, L. Pur, B. Kiran, Z. Gulbaran, P. Cagatay, F. Erkan (Istanbul, Turkey). Can plasma arginase levels differantiate asthma and COPD?. Eur Respir J 2007; 30: Suppl. 51, 2226
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap
Source: Eur Respir J 2014; 43: 421-429
Year: 2013
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Changes of urotensin II in induced sputum and plasma of patients with COPD and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 672s
Year: 2006
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Variability in eosinophil levels at start of severe exacerbations of COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
The study of bronchospastic eicosanoids levels in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003
Plasma eotaxin level in children with acute bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 314s
Year: 2003
Serum levels of interleukin-18 in patients affected by allergic bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 30s
Year: 2002
Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005
Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Comparable serum periostin levels among a Japanese population with asthma, COPD, and asthma-COPD overlap
Source: International Congress 2017 – Many faces of asthma assessment
Year: 2017
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Same role and same treatment for airway eosinophilia in asthma and COPD?
Source: Eur Respir J 2007; 29: 831-833
Year: 2007
Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis
Source: Eur Respir J 2015; 46: 1501-1503
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept